STOCKWATCH
·
Pharmaceuticals
Joint Venture1 Apr 2025, 01:40 pm

Aarti Pharmalabs Ltd Enters Addendum to Subscription and Shareholders' Agreement with Hemant Bandodkar & Family

AI Summary

Aarti Pharmalabs Ltd has executed an Addendum to the Subscription and Shareholders Agreement with Hemant Bandodkar & Family. The agreement establishes Ganesh Polychem Limited as a Joint Venture Company of APL, effective from the close of business hours of 31st March 2025. The agreement does not grant any special rights to the parties, and no fresh issuance of shares is planned. The agreement will be consolidated following the Equity Method of consolidation from 1st April 2025.

Key Highlights

  • Aarti Pharmalabs Ltd has executed an Addendum to the Subscription and Shareholders Agreement with Hemant Bandodkar & Family.
  • Ganesh Polychem Limited will be a Joint Venture Company of APL, effective from the close of business hours of 31st March 2025.
  • No special rights have been granted to the parties under the agreement.
  • No fresh issuance of shares is planned.
  • The agreement will be consolidated following the Equity Method of consolidation from 1st April 2025.
AARTIPHARM
Pharmaceuticals
Aarti Pharmalabs Ltd

Price Impact